Antinuclear antibodies, affective disorders and lithium therapy.
The prevalence of positive antinuclear antibody (ANA) was investigated in a group of patients suffering from recurrent affective disorders who had been treated for more than one year with lithium carbonate. There was no  increase of ANA in these patients (8%) as compared with a group of patients suffering from affective disorders (7.5%), but untreated with lithium salts, or with the prevalence of ANA in the general population (9%) of the same age group.
D000342:Affective Symptoms / Q000188:drug therapy / Q000276:immunology*; D000974:Antibodies, Antinuclear / Q000032:analysis*; D005260:Female; D006801:Humans; D008094:Lithium / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D008928:Mitochondria / Q000276:immunology
D000974:Antibodies, Antinuclear; D008094:Lithium